Osbourn, A. The Cinderella tree, Quillaja saponaria – A soap story. Plants People Planet. 2026 Mar, 8(2):439-451, PMID: 41743997

•  The Quillaja saponaria tree, native to central Chile, has historically been valued for
  its soap-like bark containing saponins, which produce foam and have traditional
  cleaning uses. Its significance escalated in the late 20th and early 21st centuries
  when scientists discovered that a major saponin component, QS-21, possesses
  potent immunostimulant properties, making it a critical adjuvant in vaccine
  formulations for diseases such as malaria, shingles, and respiratory viruses. This
  breakthrough transformed the tree's commercial importance from mainly a source for
  soap and shampoo to a key player in modern immunology. However, the reliance on
  wild harvesting of its bark has raised sustainability concerns due to high demand
  and limited cultivation efforts, prompting efforts to engineer biosynthesis of QS-21
  through biotechnology and develop sustainable production methods.
• Recent research has elucidated the complete biosynthetic pathway of QS-21, a
  complex immunostimulatory saponin derived from Quillaja Saponaria. The pathway
  has been successfully reconstituted in heterologous systems such as tobacco and
  yeast, demonstrating the potential for sustainable, large-scale bioproduction of QS-
  21 outside wild harvesting. Additionally, efforts to engineer the pathway aim to
  produce other structurally similar saponins with enhanced immunostimulatory
  efficacy and reduced toxicity. These advancements enable systematic exploration of
  structure-activity relationships and open possibilities for designing next-generation
  vaccine adjuvants, reducing reliance on wild tree bark and addressing supply
  sustainability issues.
•  Limitations highlighted include the structural complexity of QS-21, which poses
  challenges for selective chemical modification to optimize its immunostimulatory
  activity and toxicity profile. Additionally, the heterologous expression systems, such
  as yeast, currently yield low amounts of QS-21, necessitating further optimization to
  achieve commercially viable production levels. There are also concerns about
  residual toxicity and reactogenicity of QS-21, which complicate its development for
  human use.
• Comment from DK: While recent advances in elucidating the QS-21 biosynthetic
  pathway and its reconstitution in heterologous systems represent important scientific
  progress with long-term potential, current evidence indicates that these approaches
  remain far from commercially viable due to low titers, complex downstream
  processing, and significant scale-up challenges. In contrast, existing plant-based
  production methods, particularly extraction from Quillaja saponaria bark, have
  demonstrated robust industrial performance and continue to support current global
  demand without evidence of supply limitation when managed under regulated
  forestry practices. Moreover, emerging clonal plantation strategies offer a near-term
  pathway to further improve scalability, consistency, and sustainability. Therefore,
  while biotechnological production platforms may play an increasing role in the future,
• Quillaja trees are likely to remain the primary and reliable source of QS-21 for the foreseeable future.

Click here to access the full scientific paper.